8-K
filed December 22, 2025, 6:59 PM ET
CIK 0001829953
other material
confidence high
sentiment neutral
materiality 0.80
Corner Growth Acquisition Shareholders Approve Extension of Business Combination Deadline to Dec 31, 2026
Corner Growth Acquisition Corp.
- Proposal to extend deadline from Dec 31, 2025 to Dec 31, 2026 approved with 925,301 votes for and 54,514 against.
- Meeting held on Oct 31, 2024; record date Nov 18, 2025; aggregate of 979,815 ordinary shares represented quorum.
- Public holders redeemed 660 Class A ordinary shares in connection with the extension vote.
- Amendment to memorandum and articles of association filed as Exhibit 3.1 to the 8-K.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001477932-25-009154
- form_type
- 8-K
- ticker
- null
- cik
- 0001829953
- company_name
- Corner Growth Acquisition Corp.
- filed_at
- 2025-12-22T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:40.675572+00:00
- generated_at
- 2026-05-16T12:27:16.049925+00:00
- sec_items
- ["5.03", "5.07", "9.01"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.8
- calibrated_materiality_score
- 0.8
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001477932-25-009154
- json_url
- https://secwatch.observer/filing/0001477932-25-009154.json
- markdown_url
- https://secwatch.observer/filing/0001477932-25-009154.md
- text_url
- https://secwatch.observer/filing/0001477932-25-009154.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1829953/000147793225009154/0001477932-25-009154-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1829953/000147793225009154/cgac_8k.htm
- generated_by_model
- deepseek-v4-flash:cloud
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
SKYE
Skye Bioscience stockholders approve 3x increase in authorized common shares to 300M
Skye Bioscience, Inc.
May 29, 2026, 4:54 PM ET
other_material
Items 5.03, 5.07, 9.01
same fact type: governance_change
same SEC item: 5.03, 5.07, 9.01
same event type: other_material
similar materiality
This filing
to amend the Company’s Charter to extend the date by which the Company has to consummate a business combination from December 31, 2025 to December 31, 2026
Comparable filing
On May 28, 2026, Skye Bioscience, Inc., a Nevada corporation (the “Company”) filed a Certificate of Amendment to the Company’s Articles of Incorporation (the “Articles”) with the Nevada Secretary of State, to amend Section 1 of Article IV of the Articles to increase the number of authorized shares of common stock, par value $0.001 per share (the “common stock”), of the Company from 100,000,000 to 300,000,000 (the “Charter Amendment”).
Filing page
SEC filing
BSAA
BEST SPAC I extends deadline to June 2027; over 5.3M shares redeemed (~72%)
BEST SPAC I Acquisition Corp.
May 19, 2026, 4:27 PM ET
other_material
Items 5.03, 5.07, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 5.07, 9.01
same event type: other_material
similar materiality
This filing
to amend the Company’s Charter to extend the date by which the Company has to consummate a business combination from December 31, 2025 to December 31, 2026
Comparable filing
On May 19, 2026, BEST SPAC I Acquisition Corp. (the “Company”) held its extraordinary general meeting (the “EGM”), at which the shareholders voted on the proposal to amend and restate the Company’s amended and restated memorandum and articles of association to extend the date by which it has to consummate a business combination for an additional twelve (12) months from June 16, 2026 to June 16, 2027
Filing page
SEC filing
CETX
Cemtrex announces 1-for-15 reverse stock split effective June 5, 2026 to regain Nasdaq compliance
CEMTREX INC
June 2, 2026, 4:15 PM ET
other_material
Items 3.03, 5.03, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: other_material
similar materiality
This filing
to amend the Company’s Charter to extend the date by which the Company has to consummate a business combination from December 31, 2025 to December 31, 2026
Comparable filing
On June 2, 2026, the Company filed a Certificate of Amendment to its Certificate of Incorporation (the “Charter Amendment”) with the Secretary of State of the State of Delaware, pursuant to which, effective at 12:01 a.m. Eastern Time on June 5, 2026, the Reverse Split will be effected.
Filing page
SEC filing
DGAC
Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE
DISCIPLINED GROWTH ACQUISITION Corp
June 1, 2026, 4:15 PM ET
other_material
Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: other_material
similar materiality
This filing
to amend the Company’s Charter to extend the date by which the Company has to consummate a business combination from December 31, 2025 to December 31, 2026
Comparable filing
On May 26, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”) with the Cayman Islands Registrar of Companies, which was effective on May 26, 2026.
Filing page
SEC filing
STSS
Sharps Technology rebrands as SkyAI, pivots to AI finance platform for Global South
Sharps Technology Inc.
June 1, 2026, 8:15 AM ET
other_material
Items 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: other_material
similar materiality
This filing
to amend the Company’s Charter to extend the date by which the Company has to consummate a business combination from December 31, 2025 to December 31, 2026
Comparable filing
filed a Certificate of Amendment to its articles of incorporation (the “Amendment”) to change the name of the Company to SkyAI, Inc.
Filing page
SEC filing
ZSPC
zSpace restructures $12M debt via equity conversion; creates Series P-2 preferred
zSpace, Inc.
June 1, 2026, 8:00 AM ET
other_material
Items 1.01, 1.02, 2.03, 3.02, 5.03, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: other_material
similar materiality
This filing
to amend the Company’s Charter to extend the date by which the Company has to consummate a business combination from December 31, 2025 to December 31, 2026
Comparable filing
On May 28, 2026, the Board approved a Certificate of Designations of Series P-2 Convertible Preferred Stock of zSpace, Inc. (the “Series P-2 COD”), creating a new series of preferred stock designated as “Series P-2 Convertible Preferred Stock” upon filing with the Secretary of State of the State of Delaware.
Filing page
SEC filing
ELOX
Eloxx Pharma: 1-for-11 reverse stock split effective May 29; appoints two independent directors
Eloxx Pharmaceuticals, Inc.
June 1, 2026, 7:00 AM ET
other_material
Items 3.02, 3.03, 5.03, 5.02, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: other_material
similar materiality
This filing
to amend the Company’s Charter to extend the date by which the Company has to consummate a business combination from December 31, 2025 to December 31, 2026
Comparable filing
On May 29, 2026, the Company filed with the Secretary of State of the State of Delaware (the "Delaware Secretary of State") a Certificate of Amendment to its Certificate of Incorporation (the "Certificate of Amendment") to effect the Reverse Stock Split and Authorized Share Reduction.
Filing page
SEC filing
FDXF
FedEx Freight completes spin-off from FedEx; $600M drawn, new board and executives appointed
FedEx Freight Holding Company, Inc.
June 1, 2026, 6:46 AM ET
other_material
Items 1.01, 2.03, 3.03, 5.03, 5.01, 5.02, 5.05, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: other_material
similar materiality
This filing
to amend the Company’s Charter to extend the date by which the Company has to consummate a business combination from December 31, 2025 to December 31, 2026
Comparable filing
As of 9:30 a.m., Eastern Time, on May 27, 2026, the certificate of incorporation of the Company was amended by the certificate of amendment to the certificate of incorporation of the Company (the “Certificate of Amendment”), which, among other things, (i) created and authorized 500,000,000 shares of the Company’s common stock, par value $0.10 per share (the “Common Stock”), and (ii) converted the total number of shares of the Common Stock issued and outstanding into a number of validly issued, fully paid, and non-assessable shares of the Common Stock authorized for issuance pursuant to the Certificate of Amendment equal to 149,505,248.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.